B+
Bull case
25%
Probability
Target price
$4.50
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
HSCS
HeartSciencesFNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
A successful 510(k) clearance plus even modest commercial proof could re-rate a sub-$10 million equity quickly because the current valuation implies very little success.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.0.
What can break
Commercial adoption may remain slow even if regulatory progress continues.
Momentum
81
Value
37
Sentiment
2
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1.20 · Bull $4.50 · Bear $0.35Analysis 2026-04-15; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-04-15 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $12.00
Why
Momentum81 · Δ7d -
Value37 · Δ7d -0.0
Sentiment2 · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Commercial adoption may remain slow even if regulatory progress continues.
- • FDA timing or non-clearance risk for the MyoVista wavECG device.
- • The company still faces going-concern language, needs more capital, and carries financing structures that can amplify dilution before commercialization is proven.
Catalyst clock
2026-06-30
Financing overhang and dilution risk stays front-and-center
Lead driver: Value · See fundamentals
Momentum
81
9% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
37
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.2
Sentiment
2
62% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 80.6 / Value 36.6 / Sentiment 2.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-04-15. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$1.20
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$0.35
Analysis reference price unavailable
Analysis 2026-04-15 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$8.62M
Beta
2.53
Shares Out
3.9M
P/E (TTM) · Derived
-0.6
P/S (TTM)
1129.05
P/FCF (TTM) · Derived
-0.66
Rev YoY
-100.0%
EPS YoY
-54.1%
Gross Margin
-2981.5%
Op Margin
-95033.3%
Net Debt
$2.28M
Current Ratio
0.50
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data